Thus, the new YT–Vav1+CISH–/– and YT–Vav1+B2M–/– modified NK cell lines demonstrate greater cytotoxic activity against primary patient’s glioblastoma spheroids compared with the standard line, causing early metabolic rearrangements and evident decrease of tumor cells viability. The gene discussed is VAV1; the disease is neoplasm.